Skip to main content Accessibility help
  • Print publication year: 2013
  • Online publication date: June 2014


Suggested reading

Brown P, Steiger MJ, Thompson PD, Rothwell JC, Day BL, Salama M, Waegemans T, Marsden CD. Effectiveness of piracetam in cortical myoclonus. Movement Disorders 1993; 8: 63–68.
Koskiniemi M, van Vleyman B, Hakamies L, Lamusuo S, Taalas J. Piracetam relieves symptoms in progressive myoclonic epilepsy: a multicentre, randomised, double-blind, crossover study comparing the efficacy and safety of three dosages of oral piracetam with placebo. Journal of Neurology, Neurosurgery, and Psychiatry 1998; 64: 344–348.
Obeso JA, Artieda J, Quinn N, Rothwell JC, Luquin MR, Vaamonde J, Marsden CD. Piracetam in the treatment of different types of myoclonus. Clinical Neuropharmacology 1988; 11: 529–536.
Shorvon SD. Pyrrolidine derivatives. Lancet 2001; 358: 1885–1892.